Persistence Evaluation and Response Study for Immunotherapy Safety Tracking of Participants Who Receive an AvenCell CAR-T Cell Therapy

Study Summary

The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of patients who participated in an AvenCell-sponsored clinical trial and received treatment with AvenCell's UniCAR or RevCAR platforms.

Interventions

Study Locations

Facility	City	State	Country
Charité Universitätsmedizin Berlin	Berlin		Germany
Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus	Dresden		Germany
Universitätsklinikum Marburg	Marburg		Germany
Klinikum der Universität (LMU) Muenchen	Munich		Germany
Universitatsklinikum Ulm	Ulm		Germany

Official Trial Information

View on ClinicalTrials.gov